Similar articles

• Azithromycin extended-release (Zmax) for sinusitis and pneumonia.

  [No authors listed] [No authors listed] Obstet Gynecol. 2006 Jan;107(1):180-2. doi: 10.1097/01.AOG.0000195219.71794.16. Obstet Gynecol. 2006. PMID: 16394059 Review. No abstract available.
• Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.

  Swainston Harrison T, Keam SJ. Swainston Harrison T, et al. Drugs. 2007;67(5):773-92. doi: 10.2165/00003495-200767050-00010. Drugs. 2007. PMID: 17385947 Review.
• Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?

  Halpern MT, Cifaldi MA. Halpern MT, et al. Clin Infect Dis. 2004 Jul 1;39(1):144-5; author reply 145-6. doi: 10.1086/392507. Clin Infect Dis. 2004. PMID: 15206068 No abstract available.
• Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.

  Ehnhage A, Rautiainen M, Fang AF, Sanchez SP. Ehnhage A, et al. Int J Antimicrob Agents. 2008 Jun;31(6):561-6. doi: 10.1016/j.ijantimicag.2008.01.027. Epub 2008 May 5. Int J Antimicrob Agents. 2008. PMID: 18456465 Clinical Trial.
• Distraction delays a dose.

  Lilley LL, Guanci R. Lilley LL, et al. Am J Nurs. 1998 Feb;98(2):12. Am J Nurs. 1998. PMID: 9473978 No abstract available.